Tirzepatide
GIP + GLP-1 medication
A highly effective dual-pathway option for provider-guided weight care.
A once-weekly treatment that works with two metabolic signaling pathways for eligible adults.
Discuss this optionWhat is Tirzepatide?
Tirzepatide works with both GIP and GLP-1 receptors. In weight care, this dual action can support appetite regulation, reduced food intake, and long-term weight management when paired with a provider-led plan.
Zepbound is the tirzepatide product approved for chronic weight management in certain eligible adults. Other tirzepatide products have different approved uses, and compounded products are not FDA approved. Important warnings and contraindications apply, including a boxed warning related to thyroid C-cell tumors.
Works across two signaling pathways
GIP and GLP-1 are involved in appetite, food intake, and metabolic regulation. Tirzepatide activates both pathways. A provider determines whether its effects, risks, and treatment format fit your individual health profile.
Why patients ask about it
- Supports appetite regulation through two hormone pathways
- Demonstrated substantial average weight reduction in large clinical trials of branded tirzepatide
- Designed for chronic weight management in eligible adults
- A branded tirzepatide product also has a specific indication for moderate to severe obstructive sleep apnea in certain adults with obesity*
What thoughtful care looks like.
The right treatment is not selected from a menu alone. It follows an individual review and a plan for monitoring.
Your provider reviews health history, medicines, and treatment goals.
The plan starts only when the provider determines it is appropriate.
Dose changes are gradual and directed by the prescribing provider.
Follow-up helps the care team assess response and tolerability.
Common effects to discuss.
Gastrointestinal effects are common with this medication class, especially while the body adjusts. A provider can explain what is expected, what may help, and when to seek care.
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal discomfort
This is not a complete list of side effects, warnings, interactions, or contraindications.
What patients often want to know.
How is tirzepatide different from semaglutide?
Semaglutide acts on the GLP-1 pathway. Tirzepatide acts on both GIP and GLP-1 pathways. A provider considers your history, goals, tolerability, access, and other clinical factors when discussing options.
Can I request tirzepatide during intake?
You can share your preferences and questions. The final recommendation, if any, depends on a provider’s clinical assessment and the options actually available to you.
Does online care still include follow-up?
Yes. Responsible medication care includes a plan for monitoring response, discussing side effects, and making provider-directed adjustments when needed.
Bring your questions. We’ll start with your health.
A completed intake helps a licensed provider understand whether this option may belong in your care plan.
Begin your intake